Skip to main content
. 2009 Aug 1;32(8):979–983. doi: 10.1093/sleep/32.8.979

Table 3.

Sensitivity and specificity of DQB1*0602 positivity in combination with anti-streptolysin O (ASO) ≥ 200 IU and /or anti DNAse B (ADB) ≥ 480 IU

Interval from onset of symptoms ASO and HLA positive ASO or ADB and HLA positive ASO and ADB and HLA positive
Up to 1 year (n = 23) Sensitivity 61% Sensitivity 65% Sensitivity 43%
Specificity 96% Specificity 91% Specificity 100%
1-3 years (n = 42) Sensitivity 45% Sensitivity 57% Sensitivity 33%
Specificity 92% Specificity 86% Specificity 95%